Information:
Fel:
ID
13894
Beskrivning
A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.; ODM derived from: https://clinicaltrials.gov/show/NCT01427010
Länk
https://clinicaltrials.gov/show/NCT01427010
Nyckelord
Versioner (1)
- 2016-03-13 2016-03-13 -
Uppladdad den
13 mars 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Recurrent and Second Primary Squamous Cell Carcinoma of the Oral Cavity in the Previously Irradiated Territory in Case of Primary Unresectable Tumor. NCT01427010
Eligibility Recurrent and Second Primary Squamous Cell Carcinoma of the Oral Cavity in the Previously Irradiated Territory in Case of Primary Unresectable Tumor. NCT01427010
Similar models
Eligibility Recurrent and Second Primary Squamous Cell Carcinoma of the Oral Cavity in the Previously Irradiated Territory in Case of Primary Unresectable Tumor. NCT01427010
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
recurrence squamous cell carcinoma of the oral cavity
Item
histologically confirmed recurrences and second primary squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx in the previously irradiated territory.
boolean
C0034897 (UMLS CUI [1,1])
C0585362 (UMLS CUI [1,2])
C0585362 (UMLS CUI [1,2])
Tumor surgically unresectable
Item
primary unresectable tumor and/or patients refused surgery.
boolean
C4039777 (UMLS CUI [1])
late toxicity; xerostomia; Chemoradiotherapy; Cancer of Head and Neck
Item
no grade 3 or more late toxicity (except xerostomia) after the initial radio(chemo)therapy for primary head and neck cancer.
boolean
C2198186 (UMLS CUI [1])
C0043352 (UMLS CUI [2])
C0436307 (UMLS CUI [3])
C0278996 (UMLS CUI [4])
C0043352 (UMLS CUI [2])
C0436307 (UMLS CUI [3])
C0278996 (UMLS CUI [4])
Chemoradiotherapy; Cancer of Head and Neck
Item
minimal interval 12 months after the initial radio(chemo)therapy for primary head and neck cancer.
boolean
C0436307 (UMLS CUI [1])
C0278996 (UMLS CUI [2])
C0278996 (UMLS CUI [2])
radiotherapy; Targeted Therapy; cetuximab
Item
decision of a multidisciplinary tumor board on curative radiotherapy (in combination or not with targeted therapy with cetuximab)
boolean
C1522449 (UMLS CUI [1])
C2985566 (UMLS CUI [2])
C0995188 (UMLS CUI [3])
C2985566 (UMLS CUI [2])
C0995188 (UMLS CUI [3])
karnofsky performance status
Item
karnofsky performance status ≥70%.
boolean
C0206065 (UMLS CUI [1])
age
Item
age ≥ 18 years old.
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
informed consent obtained, signed and dated before specific protocol procedures.
boolean
C0021430 (UMLS CUI [1])
radiotherapy
Item
previous radiotherapy for ct1-2 cn0 m0 glottic cancer.
boolean
C1522449 (UMLS CUI [1])
brachytherapy; recurrence
Item
brachytherapy as treatment for second primary / recurrence.
boolean
C0034897 (UMLS CUI [1])
metastases
Item
distant metastases.
boolean
C0027627 (UMLS CUI [1])
primary tumor
Item
other second primary tumors that are not under control.
boolean
C0677930 (UMLS CUI [1])
pregnancy; lactating
Item
pregnant or lactating women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
blood creatinine level
Item
elevated blood creatinine level.
boolean
C3516328 (UMLS CUI [1])
hypersensitivity contrast agent
Item
allergy to the ct-contrast agents.
boolean
C0020517 (UMLS CUI [1,1])
C0009924 (UMLS CUI [1,2])
C0009924 (UMLS CUI [1,2])
Compliance behavior Limited mental condition
Item
mental condition rendering the patient unable to understand the nature, scope, and possible consequences of the study.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C3840291 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C3840291 (UMLS CUI [1,3])
compliance
Item
patient unlikely to comply with protocol, i.e. uncooperative attitude, inability to return for follow-up visits, and unlikely to complete the study.
boolean
C1321605 (UMLS CUI [1])